|
OXCT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.675060E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.441400E-04 |
| Normal-vs-Stage2 |
5.240000E-03 |
| Normal-vs-Stage3 |
1.783860E-03 |
| Normal-vs-Stage4 |
2.43729999960252E-07 |
| Stage1-vs-Stage2 |
8.985200E-01 |
| Stage1-vs-Stage3 |
8.792600E-01 |
| Stage1-vs-Stage4 |
2.111900E-02 |
| Stage2-vs-Stage3 |
8.027800E-01 |
| Stage2-vs-Stage4 |
3.568000E-02 |
| Stage3-vs-Stage4 |
6.261900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.467540E-02 |
| Normal-vs-AfricanAmerican |
1.974550E-04 |
| Normal-vs-Asian |
6.822200E-03 |
| Caucasian-vs-AfricanAmerican |
3.668200E-01 |
| Caucasian-vs-Asian |
1.916750E-01 |
| AfricanAmerican-vs-Asian |
4.771200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.898900E-03 |
| Normal-vs-Female |
1.154350E-02 |
| Male-vs-Female |
6.946600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.445400E-01 |
| Normal-vs-Extreme_Weight |
1.619010E-01 |
| Normal-vs-Obese |
7.98990000000499E-05 |
| Normal-vs-Extreme_Obese |
1.790070E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.710000E-01 |
| Normal_Weight-vs-Obese |
4.409200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.986800E-01 |
| Extreme_Weight-vs-Obese |
5.723200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.368000E-01 |
| Obese-vs-Extreme_Obese |
7.957600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.65920000000575E-05 |
| Normal-vs-Age(41-60Yrs) |
6.00970000430578E-08 |
| Normal-vs-Age(61-80Yrs) |
1.737360E-01 |
| Normal-vs-Age(81-100Yrs) |
2.988000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.955190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.594500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.725900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.039970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.406000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.721000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.81559999993198E-07 |
| Normal-VS-Type2 PRCC |
3.536400E-01 |
| Normal-VS-KIRP CIMP |
5.91749982348233E-11 |
| Normal-VS-Unclassified PRCC |
5.360100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.926420E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.1616997081253E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
8.671700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.42070000000738E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.433020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.33349999997812E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.236400E-03 |
| Normal-vs-N1 |
1.90700000013422E-07 |
| Normal-vs-N2 |
5.49490000167907E-08 |
| N0-vs-N1 |
1.700350E-02 |
| N0-vs-N2 |
4.408600E-04 |
| N1-vs-N2 |
3.864000E-01 |
|
|
